nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—KCNH7—Circadian rythm related genes—HCRTR2—narcolepsy	0.03	0.0335	CbGpPWpGaD
Terazosin—KCNH7—Circadian rythm related genes—HCRTR1—narcolepsy	0.03	0.0335	CbGpPWpGaD
Terazosin—KCNH6—forebrain—narcolepsy	0.021	0.199	CbGeAlD
Terazosin—ADRA1D—Amine ligand-binding receptors—HRH3—narcolepsy	0.0178	0.0199	CbGpPWpGaD
Terazosin—ADRA1D—GPCRs, Other—P2RY11—narcolepsy	0.0166	0.0186	CbGpPWpGaD
Terazosin—ADRA1B—Amine ligand-binding receptors—HRH3—narcolepsy	0.0148	0.0165	CbGpPWpGaD
Terazosin—ADRA1B—AMPK Signaling—CPT1B—narcolepsy	0.0138	0.0154	CbGpPWpGaD
Terazosin—KCNH7—Circadian rythm related genes—NPS—narcolepsy	0.0136	0.0152	CbGpPWpGaD
Terazosin—ADRA1A—Amine ligand-binding receptors—HRH3—narcolepsy	0.0131	0.0147	CbGpPWpGaD
Terazosin—ADRA1A—AMPK Signaling—CPT1B—narcolepsy	0.0122	0.0137	CbGpPWpGaD
Terazosin—KCNH7—brain—narcolepsy	0.0122	0.116	CbGeAlD
Terazosin—ADRA1D—forebrain—narcolepsy	0.0116	0.11	CbGeAlD
Terazosin—ADRA1D—Monoamine GPCRs—HTR2A—narcolepsy	0.0105	0.0118	CbGpPWpGaD
Terazosin—ADRA1D—G alpha (q) signalling events—HCRTR1—narcolepsy	0.00968	0.0108	CbGpPWpGaD
Terazosin—ADRA1D—G alpha (q) signalling events—HCRTR2—narcolepsy	0.00968	0.0108	CbGpPWpGaD
Terazosin—ADRA1D—G alpha (q) signalling events—P2RY11—narcolepsy	0.00935	0.0105	CbGpPWpGaD
Terazosin—ADRA1D—Amine ligand-binding receptors—HTR2A—narcolepsy	0.00887	0.00991	CbGpPWpGaD
Terazosin—ADRA1B—Monoamine GPCRs—HTR2A—narcolepsy	0.00875	0.00979	CbGpPWpGaD
Terazosin—KCNH6—brain—narcolepsy	0.0087	0.0824	CbGeAlD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.00866	0.00968	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.00866	0.00968	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00836	0.00935	CbGpPWpGaD
Terazosin—ADRA1B—G alpha (q) signalling events—HCRTR1—narcolepsy	0.00803	0.00898	CbGpPWpGaD
Terazosin—ADRA1B—G alpha (q) signalling events—HCRTR2—narcolepsy	0.00803	0.00898	CbGpPWpGaD
Terazosin—ADRA1D—G alpha (q) signalling events—HCRT—narcolepsy	0.00795	0.00889	CbGpPWpGaD
Terazosin—ADRA1A—Monoamine GPCRs—HTR2A—narcolepsy	0.00778	0.00869	CbGpPWpGaD
Terazosin—ADRA1B—G alpha (q) signalling events—P2RY11—narcolepsy	0.00776	0.00867	CbGpPWpGaD
Terazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00748	0.00836	CbGpPWpGaD
Terazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00748	0.00836	CbGpPWpGaD
Terazosin—ADRA1B—Amine ligand-binding receptors—HTR2A—narcolepsy	0.00736	0.00823	CbGpPWpGaD
Terazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00723	0.00808	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.00718	0.00803	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.00718	0.00803	CbGpPWpGaD
Terazosin—ADRA1A—G alpha (q) signalling events—HCRTR2—narcolepsy	0.00714	0.00798	CbGpPWpGaD
Terazosin—ADRA1A—G alpha (q) signalling events—HCRTR1—narcolepsy	0.00714	0.00798	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00711	0.00795	CbGpPWpGaD
Terazosin—KCNH2—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00703	0.00786	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00694	0.00776	CbGpPWpGaD
Terazosin—ADRA1A—brainstem—narcolepsy	0.00691	0.0655	CbGeAlD
Terazosin—ADRA1A—G alpha (q) signalling events—P2RY11—narcolepsy	0.00689	0.0077	CbGpPWpGaD
Terazosin—ADRA1A—forebrain—narcolepsy	0.00667	0.0632	CbGeAlD
Terazosin—ADRA1B—G alpha (q) signalling events—HCRT—narcolepsy	0.0066	0.00738	CbGpPWpGaD
Terazosin—ADRA1A—Amine ligand-binding receptors—HTR2A—narcolepsy	0.00654	0.00731	CbGpPWpGaD
Terazosin—KCNH2—forebrain—narcolepsy	0.00644	0.061	CbGeAlD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00641	0.00717	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00641	0.00717	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.00638	0.00714	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.00638	0.00714	CbGpPWpGaD
Terazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00621	0.00694	CbGpPWpGaD
Terazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00621	0.00694	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00619	0.00692	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00616	0.00689	CbGpPWpGaD
Terazosin—ADRA1D—G alpha (q) signalling events—TRH—narcolepsy	0.00602	0.00673	CbGpPWpGaD
Terazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.006	0.00671	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.0059	0.0066	CbGpPWpGaD
Terazosin—ADRA1A—G alpha (q) signalling events—HCRT—narcolepsy	0.00586	0.00655	CbGpPWpGaD
Terazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00552	0.00617	CbGpPWpGaD
Terazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00552	0.00617	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00539	0.00602	CbGpPWpGaD
Terazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00533	0.00596	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00532	0.00595	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00532	0.00595	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00526	0.00589	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00524	0.00586	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00514	0.00574	CbGpPWpGaD
Terazosin—ADRA1B—G alpha (q) signalling events—TRH—narcolepsy	0.005	0.00559	CbGpPWpGaD
Terazosin—ADRA1B—brain—narcolepsy	0.00493	0.0467	CbGeAlD
Terazosin—ADRA1D—GPCR ligand binding—HCRTR2—narcolepsy	0.00488	0.00546	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—HCRTR1—narcolepsy	0.00488	0.00546	CbGpPWpGaD
Terazosin—ADRA1D—brain—narcolepsy	0.00482	0.0457	CbGeAlD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00473	0.00528	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00473	0.00528	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—P2RY11—narcolepsy	0.00471	0.00527	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00469	0.00525	CbGpPWpGaD
Terazosin—ADRA1D—GPCRs, Other—HTR2A—narcolepsy	0.00468	0.00524	CbGpPWpGaD
Terazosin—KCNH2—medulla oblongata—narcolepsy	0.00465	0.0441	CbGeAlD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00456	0.0051	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00447	0.005	CbGpPWpGaD
Terazosin—ADRA1A—G alpha (q) signalling events—TRH—narcolepsy	0.00444	0.00496	CbGpPWpGaD
Terazosin—ADRA1D—G alpha (q) signalling events—TAC1—narcolepsy	0.00438	0.00489	CbGpPWpGaD
Terazosin—ADRA1D—G alpha (q) signalling events—NPS—narcolepsy	0.00438	0.00489	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00437	0.00488	CbGpPWpGaD
Terazosin—KCNH2—midbrain—narcolepsy	0.00425	0.0403	CbGeAlD
Terazosin—KCNH2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00423	0.00473	CbGpPWpGaD
Terazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00408	0.00456	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—HCRTR2—narcolepsy	0.00405	0.00453	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—HCRTR1—narcolepsy	0.00405	0.00453	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—HCRT—narcolepsy	0.00401	0.00448	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00399	0.00446	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00397	0.00444	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00391	0.00438	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00391	0.00438	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—P2RY11—narcolepsy	0.00391	0.00437	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00389	0.00435	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00388	0.00434	CbGpPWpGaD
Terazosin—ADRA1B—G alpha (q) signalling events—NPS—narcolepsy	0.00363	0.00406	CbGpPWpGaD
Terazosin—ADRA1B—G alpha (q) signalling events—TAC1—narcolepsy	0.00363	0.00406	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—HCRTR1—narcolepsy	0.0036	0.00402	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—HCRTR2—narcolepsy	0.0036	0.00402	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—PENK—narcolepsy	0.00357	0.00399	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.0035	0.00391	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—P2RY11—narcolepsy	0.00348	0.00389	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00346	0.00387	CbGpPWpGaD
Terazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00339	0.00379	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—HCRT—narcolepsy	0.00333	0.00372	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00331	0.0037	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00325	0.00363	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00325	0.00363	CbGpPWpGaD
Terazosin—ADRA1A—G alpha (q) signalling events—TAC1—narcolepsy	0.00323	0.00361	CbGpPWpGaD
Terazosin—ADRA1A—G alpha (q) signalling events—NPS—narcolepsy	0.00323	0.00361	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—HLA-DQA1—narcolepsy	0.00318	0.00355	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—TRH—narcolepsy	0.00304	0.0034	CbGpPWpGaD
Terazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00301	0.00337	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—HLA-DQB1—narcolepsy	0.00297	0.00332	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—PENK—narcolepsy	0.00297	0.00332	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—HCRT—narcolepsy	0.00296	0.0033	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00294	0.00329	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.0029	0.00325	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.0029	0.00324	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.0029	0.00324	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00289	0.00323	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00289	0.00323	CbGpPWpGaD
Terazosin—ABCB1—forebrain—narcolepsy	0.00283	0.0268	CbGeAlD
Terazosin—ADRA1A—brain—narcolepsy	0.00277	0.0262	CbGeAlD
Terazosin—ADRA1D—GPCR downstream signaling—HCRTR2—narcolepsy	0.00276	0.00308	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—HCRTR1—narcolepsy	0.00276	0.00308	CbGpPWpGaD
Terazosin—KCNH2—brain—narcolepsy	0.00267	0.0253	CbGeAlD
Terazosin—ADRA1D—GPCR downstream signaling—P2RY11—narcolepsy	0.00266	0.00298	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—HRH3—narcolepsy	0.00266	0.00298	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—PENK—narcolepsy	0.00263	0.00294	CbGpPWpGaD
Terazosin—ADRA1D—G alpha (q) signalling events—HTR2A—narcolepsy	0.00263	0.00294	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00258	0.00288	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—TRH—narcolepsy	0.00252	0.00282	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—HCRTR1—narcolepsy	0.00251	0.0028	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—HCRTR2—narcolepsy	0.00251	0.0028	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—P2RY11—narcolepsy	0.00242	0.0027	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00241	0.00269	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00241	0.00269	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00235	0.00263	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—HCRTR1—narcolepsy	0.00229	0.00256	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—HCRTR2—narcolepsy	0.00229	0.00256	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—HCRT—narcolepsy	0.00227	0.00253	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—HLA-DRB1—narcolepsy	0.00226	0.00253	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—TRH—narcolepsy	0.00224	0.0025	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—P2RY11—narcolepsy	0.00221	0.00247	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—HRH3—narcolepsy	0.00221	0.00247	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—TAC1—narcolepsy	0.00221	0.00247	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—NPS—narcolepsy	0.00221	0.00247	CbGpPWpGaD
Terazosin—ADRA1B—G alpha (q) signalling events—HTR2A—narcolepsy	0.00219	0.00244	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00214	0.00239	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00214	0.00239	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—HCRTR2—narcolepsy	0.00208	0.00232	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—HCRTR1—narcolepsy	0.00208	0.00232	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—HCRT—narcolepsy	0.00206	0.0023	CbGpPWpGaD
Terazosin—ABCB1—medulla oblongata—narcolepsy	0.00204	0.0193	CbGeAlD
Terazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00204	0.00228	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—HCRTR2—narcolepsy	0.00203	0.00227	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—HCRTR1—narcolepsy	0.00203	0.00227	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—PENK—narcolepsy	0.00202	0.00226	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—P2RY11—narcolepsy	0.00201	0.00224	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—P2RY11—narcolepsy	0.00196	0.0022	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—HRH3—narcolepsy	0.00196	0.0022	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00195	0.00219	CbGpPWpGaD
Terazosin—ADRA1A—G alpha (q) signalling events—HTR2A—narcolepsy	0.00194	0.00217	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—HCRT—narcolepsy	0.00188	0.0021	CbGpPWpGaD
Terazosin—ABCB1—midbrain—narcolepsy	0.00187	0.0177	CbGeAlD
Terazosin—ADRA1A—Signaling by GPCR—HCRTR1—narcolepsy	0.00185	0.00206	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—HCRTR2—narcolepsy	0.00185	0.00206	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—PENK—narcolepsy	0.00183	0.00205	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—TAC1—narcolepsy	0.00183	0.00205	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—NPS—narcolepsy	0.00183	0.00205	CbGpPWpGaD
Terazosin—KCNH2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00182	0.00203	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—P2RY11—narcolepsy	0.00178	0.00199	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00174	0.00195	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00174	0.00194	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—TRH—narcolepsy	0.00172	0.00192	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—HCRT—narcolepsy	0.00171	0.00191	CbGpPWpGaD
Terazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00169	0.00189	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—PENK—narcolepsy	0.00168	0.00187	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—HCRT—narcolepsy	0.00167	0.00187	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—NPS—narcolepsy	0.00163	0.00182	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—TAC1—narcolepsy	0.00163	0.00182	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—TRH—narcolepsy	0.00156	0.00174	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PENK—narcolepsy	0.00152	0.0017	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—HCRT—narcolepsy	0.00152	0.0017	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—HRH3—narcolepsy	0.00151	0.00168	CbGpPWpGaD
Terazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.0015	0.00168	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PENK—narcolepsy	0.00149	0.00166	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HCRTR1—narcolepsy	0.00148	0.00165	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HCRTR2—narcolepsy	0.00148	0.00165	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00145	0.00162	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—P2RY11—narcolepsy	0.00143	0.0016	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—TRH—narcolepsy	0.00142	0.00159	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—HRH3—narcolepsy	0.00137	0.00153	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PENK—narcolepsy	0.00135	0.00151	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—HTR2A—narcolepsy	0.00133	0.00148	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—TRH—narcolepsy	0.00129	0.00145	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00129	0.00144	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—TRH—narcolepsy	0.00127	0.00142	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—HRH3—narcolepsy	0.00125	0.0014	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—TAC1—narcolepsy	0.00125	0.00139	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—NPS—narcolepsy	0.00125	0.00139	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HCRTR1—narcolepsy	0.00123	0.00137	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HCRTR2—narcolepsy	0.00123	0.00137	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HCRT—narcolepsy	0.00122	0.00136	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—P2RY11—narcolepsy	0.00119	0.00133	CbGpPWpGaD
Terazosin—ABCB1—brain—narcolepsy	0.00117	0.0111	CbGeAlD
Terazosin—ADRA1A—Signaling by GPCR—TRH—narcolepsy	0.00115	0.00128	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—HRH3—narcolepsy	0.00113	0.00127	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—NPS—narcolepsy	0.00113	0.00127	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—TAC1—narcolepsy	0.00113	0.00127	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—HRH3—narcolepsy	0.00111	0.00124	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—HTR2A—narcolepsy	0.0011	0.00123	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HCRTR2—narcolepsy	0.00109	0.00122	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HCRTR1—narcolepsy	0.00109	0.00122	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PENK—narcolepsy	0.00108	0.00121	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—TNF—narcolepsy	0.00107	0.00119	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—P2RY11—narcolepsy	0.00105	0.00118	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—TAC1—narcolepsy	0.00104	0.00116	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—NPS—narcolepsy	0.00104	0.00116	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HCRT—narcolepsy	0.00101	0.00113	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—HRH3—narcolepsy	0.00101	0.00113	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—HTR2A—narcolepsy	0.000979	0.00109	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CHKB—narcolepsy	0.000952	0.00106	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—TAC1—narcolepsy	0.00094	0.00105	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—NPS—narcolepsy	0.00094	0.00105	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TRH—narcolepsy	0.000921	0.00103	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—TAC1—narcolepsy	0.00092	0.00103	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—NPS—narcolepsy	0.00092	0.00103	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PENK—narcolepsy	0.000899	0.00101	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HCRT—narcolepsy	0.000896	0.001	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—NPS—narcolepsy	0.000835	0.000934	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—TAC1—narcolepsy	0.000835	0.000934	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HRH3—narcolepsy	0.000808	0.000903	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PENK—narcolepsy	0.000799	0.000893	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TRH—narcolepsy	0.000764	0.000855	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—HTR2A—narcolepsy	0.00075	0.000839	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—HTR2A—narcolepsy	0.000681	0.000762	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TRH—narcolepsy	0.000679	0.000759	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HRH3—narcolepsy	0.00067	0.000749	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NPS—narcolepsy	0.000669	0.000748	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TAC1—narcolepsy	0.000669	0.000748	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CPT1B—narcolepsy	0.000647	0.000724	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—HTR2A—narcolepsy	0.000623	0.000696	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HRH3—narcolepsy	0.000595	0.000666	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—HTR2A—narcolepsy	0.000566	0.000632	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NPS—narcolepsy	0.000555	0.000621	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TAC1—narcolepsy	0.000555	0.000621	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—HTR2A—narcolepsy	0.000553	0.000619	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000527	0.00059	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—HTR2A—narcolepsy	0.000502	0.000562	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NPS—narcolepsy	0.000493	0.000552	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TAC1—narcolepsy	0.000493	0.000552	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HTR2A—narcolepsy	0.000403	0.00045	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HTR2A—narcolepsy	0.000334	0.000374	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HTR2A—narcolepsy	0.000297	0.000332	CbGpPWpGaD
